1. Cardiovascular disease (coronary arterial disease, cerebrovascular disease, peripheral arterial disease) 2. Conditions at high risk of cardiovascular disease (diabetes mellitus, chronic kidney disease including stage 5D) 3. Those who do not have the above diseases
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients at high-risk of cardiovascular disease (coronary arterial disease, cerebrovascular disease, peripheral arterial disease, diabetes mellitus, chronic kidney disease including those treated with dialysis, familial hypercholesterolemia), or individuals who were examined for the screening of these conditions. 2. Individuals whose cholesterol metabolism markers were already measured (serum lathosterol, campesterol, and citosterol levels)
Exclusion criteria
Exclusion criteria: 1. Participants will be opt-out when the participants and/or their family members do not want to participate in this study upon information disclosure of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cardiovascular disease (Coronary arterial disease, cerebrovascular disease, peripheral arterial disease) | — |
Countries
Japan
Contacts
Osaka City University Graduate School of Medicine Osaka City University Graduate School of Medicine